A federal judge has blocked the Trump administration’s rule requiring drugmakers to publish the list prices of prescription medications in direct-to-consumer television advertisements.

The economic cost of the of lost earnings due to cancer deaths in the U.S. was more than $94 billion in 2015, according to a new study published in JAMA Oncology.

While general support for a universal healthcare system remains at about 50% among the public, the impact to the healthcare industry is being weighed––and providers could see huge payment cuts under certain policies. 

Patients are worried about the rising cost of prescription drugs, and the high rate of cost growth has led lawmakers and the Trump administration to review steps to reduce runaway price growth. However, there are some ways for doctors to help patients avoid sticker shock on their prescriptions––and not many are using these tools, according to a report from NPR.

Breast density notification laws do not always lead to drastic changes in supplemental screening utilization, according to a new study published in the Journal of the American College of Radiology.

Five states have voiced they want to testify at an upcoming July hearing in the ongoing court review of the $69 billion CVS Health acquisition of Aetna.

Emergency services are well known for charging high prices, often leaving patients on the hook for sky-high medical bills when those services are billed out of network. In particular, patients with private insurance face far higher charges for air ambulance compared to Medicare rates, according to a recent study published in Health Affairs.

Despite a major push from the Trump administration over the last few years to lower prescription drug costs, more than 3,400 drugs have seen price hikes during the first half of the year, according to a recent report.